MIMIVAX
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 24 Feb 2025)
What this means for you
Registered since 11 Jun 2019. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 86771918
- Registration number
- 5775811
- Mark type
- Stylized text
- Filed
- 29 Sept 2015
- Published for opposition
- 08 Mar 2016
- Registered
- 11 Jun 2019
- Attorney of record
- Michael E. Storck
Goods and services
- Class 042 — Scientific and technological services: Research and development of pharmaceuticals for the prevention and treatment of cancer
Owner
- MimiVax, LLC, Buffalo, NY, US
- MimiVax, LLC, Buffalo, NY, US
- MimiVax, LLC, Buffalo, NY, US
Prosecution history
- 24 Feb 2025 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 24 Feb 2025 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 24 Feb 2025 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 17 Oct 2024 — TEAS SECTION 8 & 15 RECEIVED
- 11 Jun 2024 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 11 Jun 2019 — REGISTERED-PRINCIPAL REGISTER
- 07 May 2019 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 06 May 2019 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 17 Apr 2019 — STATEMENT OF USE PROCESSING COMPLETE
- 15 Apr 2019 — USE AMENDMENT FILED
- 15 Apr 2019 — TEAS STATEMENT OF USE RECEIVED
- 06 Nov 2018 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 05 Nov 2018 — SOU EXTENSION 5 GRANTED
- 26 Oct 2018 — SOU EXTENSION 5 FILED
- 05 Nov 2018 — CASE ASSIGNED TO INTENT TO USE PARALEGAL